This morning, the U.S. Food and Drug Administration (FDA) published detailed data regarding 72 total seafood entry line refusals in July, of which three (4.2%) were of shrimp for reasons related to banned antibiotics.  In addition to these three entry lines, another entry line of shrimp was refused for the presence of pesticides, while ten more entry lines of shrimp were refused for the presence of salmonella, nine of which were also found to be filthy.

Through July of this year, the FDA has refused a total of 48 entry lines of shrimp for reasons related to banned antibiotics and remains on track to refuse the largest number of entry lines of shrimp for veterinary drug residues since 2016.

The three shrimp entry lines refused for antibiotic residues in July were for shipments from one Indian company:

In addition to these three shipments, the Division of West Coast Imports of the FDA again also refused a shipment of shrimp from the Vietnamese exporter Tra Kha Seafood Processing Factory (F69) due to the presence of a pesticide, just as it had done in June.

Additionally, another ten (10) entry lines of shrimp from Bangladesh, Ecuador, India, and Thailand were refused for the presence of salmonella, including: